Your browser doesn't support javascript.
loading
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92.
Morelli, Eugenio; Biamonte, Lavinia; Federico, Cinzia; Amodio, Nicola; Di Martino, Maria Teresa; Gallo Cantafio, Maria Eugenia; Manzoni, Martina; Scionti, Francesca; Samur, Mehmet Kemal; Gullà, Annamaria; Stamato, Maria Angelica; Pitari, Maria Rita; Caracciolo, Daniele; Sesti, Settimio; Frandsen, Niels M; Rossi, Marco; Neri, Antonino; Fulciniti, Mariateresa; Munshi, Nikhil C; Tagliaferri, Pierosandro; Tassone, Pierfrancesco.
Afiliação
  • Morelli E; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Biamonte L; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Federico C; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Amodio N; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Di Martino MT; Cancer Biology Division, Department of Radiation Oncology, School of Medicine, Washington University in St. Louis, St. Louis, MO.
  • Gallo Cantafio ME; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Manzoni M; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Scionti F; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Samur MK; Department of Oncology and Oncoematology, University of Milan, Milan, Italy.
  • Gullà A; UOC Ematologia, Fondazione Cà Granda IRCCS, Ospedale Maggiore Policlinico, Milan, Italy.
  • Stamato MA; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Pitari MR; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Caracciolo D; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Sesti S; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Frandsen NM; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Rossi M; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Neri A; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Fulciniti M; Department of Biology, Ecology and Earth Science, University of Calabria, Cosenza, Italy.
  • Munshi NC; Exiqon A/S, Vedbaek, Denmark; and.
  • Tagliaferri P; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
  • Tassone P; Department of Oncology and Oncoematology, University of Milan, Milan, Italy.
Blood ; 132(10): 1050-1063, 2018 09 06.
Article em En | MEDLINE | ID: mdl-29997223
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligonucleotídeos / RNA Neoplásico / Apoptose / MicroRNAs / Mieloma Múltiplo Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligonucleotídeos / RNA Neoplásico / Apoptose / MicroRNAs / Mieloma Múltiplo Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article